{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:37:56Z","timestamp":1790336276482,"version":"4.1.0"},"reference-count":43,"publisher":"Hindawi Limited","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3575,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1529-8019.2005.00034.x","type":"journal-article","created":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T11:44:37Z","timestamp":1284464677000},"page":"333-340","source":"Crossref","is-referenced-by-count":65,"title":["Antihistamines and their role as antipruritics"],"prefix":"10.1155","volume":"18","author":[{"given":"Michael","family":"O'Donoghue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Tharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2005,11,17]]},"reference":[{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB1|cit1","first-page":"666","article-title":"The clinical safety of H1-receptor antagonists: an EAACI position paper","volume":"51","author":"Passalacqua","year":"1996","journal-title":"Allergy"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2165\/00003495-199957010-00004","article-title":"Second-generation antihistamines","volume":"57","author":"Slater","year":"1999","journal-title":"Drugs"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB3|cit3","first-page":"1663","article-title":"The pharmacology and use of H1-receptor antagonist drugs","volume":"330","author":"Simons","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0091-6749(03)01876-1","article-title":"H1-antihistamines: more relevant than ever in the treatment of allergic disorders","volume":"112","author":"Simons","year":"2003","journal-title":"J Allergy Clin Immuno"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMra033121","article-title":"Advances H1-antihistamines","volume":"351","author":"Simons","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/S0091-6749(03)01877-3","article-title":"Histamine: a mediator of inflammation","volume":"112","author":"MacGlashan","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2222.1997.tb00707.x","article-title":"Histamine is released in the wheal but not the flare following challenge of human skin in vivo: a microdialysis study","volume":"27","author":"Petersen","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0140-6736(03)12570-6","article-title":"Itch","volume":"361","author":"Yosipovitch","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"8003","DOI":"10.1523\/JNEUROSCI.17-20-08003.1997","article-title":"Specific C receptors for itch in human skin","volume":"17","author":"Schmelz","year":"1997","journal-title":"J Neurosci"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3959(97)03339-3","article-title":"Cutaneous field stimulation (CFS): a new powerful method to combat itch","volume":"71","author":"Nilsson","year":"1977","journal-title":"Pain"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB11|cit11","first-page":"138","article-title":"Direct evidence of neurogenic inflammation and its prevention by denervation and by treatment with capsaicin","volume":"31","author":"Jancso","year":"1967","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2165\/00003495-199040050-00009","article-title":"Cetirizine: a review of its pharmacological properties and clinical potential n allergic rhinitis, pollen-induced asthma and chronic urticaria","volume":"40","author":"Campoli-Richards","year":"1990","journal-title":"Drugs"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.1529-8019.2000.00034.x","article-title":"Second- and third-generation antihistamines","volume":"13","author":"Ellis","year":"2000","journal-title":"Dermatol Ther"},{"issue":"Suppl. 3","key":"10.1111\/j.1529-8019.2005.00034.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2222.1999.0290s3163.x","article-title":"The systemic safety of fexofenadine HCl","volume":"29","author":"Mason","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1067\/mai.2001.114239","article-title":"Desloratadine: a new, nonsedating, oral antihistamine","volume":"107","author":"Geha","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.0954-7894.2002.01314.x","article-title":"H1-antihistamines: inverse agonist, anti-inflammatory actions and cardiac effects","volume":"32","author":"Leurs","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1124\/mol.60.5.1133","article-title":"Histamine H1-receptor activation of nuclear factor-kappa B: roles for G beta gamma-and G alpha (q\/11)-subunits in constitutive and agonist-mediated signaling","volume":"60","author":"Bakker","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00003088-199528050-00006","article-title":"Pharmacokinetic-pharmacodynamic relationships H1-antihistamines","volume":"28","author":"Desager","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2165\/00003495-200161020-00006","article-title":"New insights into the second generation antihistamines","volume":"61","author":"Walsh","year":"2001","journal-title":"Drugs"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1529-8019.2000.00041.x","article-title":"The apparent volumes of distribution of H1 receptor antagonists","volume":"13","author":"Tillement","year":"2000","journal-title":"Dermatol Ther"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0091-6749(95)70183-4","article-title":"Allergens, IgE, mediators, inflammatory mechanisms: quantitation of H1-receptors antagonists in skin and serum","volume":"95","author":"Simons","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1067\/mai.2001.113080","article-title":"Skin concentrations of H1-receptor antagonists","volume":"107","author":"Simons","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1067\/mai.2002.129123","article-title":"Clinical pharmacology of H1-antihistamines in the skin","volume":"110","author":"Simons","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1034\/j.1398-9995.1999.00032.x","article-title":"A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects","volume":"54","author":"Grant","year":"1999","journal-title":"Allergy"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1081-1206(10)62483-0","article-title":"Twenty-four hours of activity of cetirizine and fexofenadine in the skin","volume":"86","author":"Purohit","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S1081-1206(10)61429-9","article-title":"Comparative activity of cetirizine and desloratadine on histamine-induced wheal-and-flare responses during 24 hours","volume":"92","author":"Purohit","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1529-8019.2000.00042.x","article-title":"The anti-inflammatory effects of the second generation antihistamines","volume":"13","author":"Walsh","year":"2000","journal-title":"Dermatol Ther"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/0091-6749(93)90198-O","article-title":"Allergic subjects express intercellular adhesion molecule-1 (ICAM_1) or (CD54) n epithelial cells of conjunctiva after allergen challenge","volume":"91","author":"Cipandi","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0091-6749(95)70324-1","article-title":"Cetirizine reduces inflammatory cell recruitment and ICAM-1 (CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge","volume":"95","author":"Cipandi","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000236407","article-title":"Protective effect of loratadine on late phase reaction induced by conjunctival provocation test","volume":"100","author":"Cipandi","year":"1994","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2165\/00003495-199855020-00012","article-title":"Fexofenadine","volume":"55","author":"Markham","year":"1998","journal-title":"Drugs"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1034\/j.1398-9995.2000.00009.x","article-title":"The clinical relevance of the anti-inflammatory properties of antihistamines","volume":"55","author":"Walsh","year":"2000","journal-title":"Allergy"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB33|cit33","first-page":"1119","article-title":"Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria","volume":"42","author":"Monroe","year":"1992","journal-title":"Arzneim Forsch"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1177\/106002809603001001","article-title":"Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria","volume":"30","author":"Breneman","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0091-6749(99)70091-6","article-title":"A double-blind, placebo-controlled trial of fexofenadine HCI in the treatment of chronic idiopathic urticaria","volume":"104","author":"Finn","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1081-1206(10)62515-X","article-title":"Fexofenadine HCL is safe and effective for treatment of chronic idiopathic urticaria","volume":"84","author":"Nelson","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1046\/j.1365-4362.2001.00186.x","article-title":"Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study","volume":"40","author":"Ring","year":"2001","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1067\/mjd.2003.143","article-title":"Efficacy and safety of desloratadine 5\u00a0mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial","volume":"48","author":"Monroe","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0889-8561(03)00066-3","article-title":"Epidemiology of atopic dermatitis","volume":"22","author":"Hanifin","year":"2002","journal-title":"Immunol Allergy Clin NA"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1056\/NEJMcp042803","article-title":"Atopic dermatitis","volume":"352","author":"Williams","year":"2005","journal-title":"New Engl J Med"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1001\/archderm.135.12.1522","article-title":"An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis","volume":"135","author":"Klein","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB42|cit42","first-page":"127","article-title":"Dose ranging study: cetirizine in the treatment of atopic dermatitis in adults","volume":"70","author":"Hannuksela","year":"1993","journal-title":"Ann Allergy"},{"key":"10.1111\/j.1529-8019.2005.00034.x-BIB43|cit43","first-page":"742","article-title":"First- or second-generation antihistamines: which are more effective at controlling pruritus?","volume":"53","author":"Crownover","year":"2004","journal-title":"J Family Prac"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1529-8019.2005.00034.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1529-8019.2005.00034.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:56:05Z","timestamp":1671818165000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1529-8019.2005.00034.x"}},"subtitle":["Antihistamines as antipruritics"],"short-title":[],"issued":{"date-parts":[[2005,11,17]]},"references-count":43,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.1111\/j.1529-8019.2005.00034.x","relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11,17]]}}}